Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
16.45
-0.50 (-2.95%)
At close: Mar 9, 2026, 4:00 PM EDT
16.63
+0.18 (1.09%)
After-hours: Mar 9, 2026, 5:31 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $2.35 billion as of March 9, 2026. Its market cap has increased by 799.24% in one year.
Market Cap
2.35B
Enterprise Value
2.02B
1-Year Change
799.24%
Ranking
Category
Stock Price
$16.45
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $2.35B, an increase of 1,401.69%. That is a compound annual growth rate of 74.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.42B | 102.69% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.64B |
| Apellis Pharmaceuticals | 2.57B |
| Travere Therapeutics | 2.51B |
| Wave Life Sciences | 2.47B |
| Dyne Therapeutics | 2.45B |
| Telix Pharmaceuticals | 2.42B |
| Immunome | 2.38B |
| Disc Medicine | 2.33B |